Serum metabolome biomarkers associate low-level environmental perfluorinated compound exposure with oxidative /nitrosative stress in humans.

[1]  Heqing Shen,et al.  Low-Level Environmental Phthalate Exposure Associates with Urine Metabolome Alteration in a Chinese Male Cohort. , 2016, Environmental science & technology.

[2]  Romà Tauler,et al.  Perfluoroalkylated Substance Effects in Xenopus laevis A6 Kidney Epithelial Cells Determined by ATR-FTIR Spectroscopy and Chemometric Analysis , 2016, Chemical research in toxicology.

[3]  L. Groop,et al.  α-Hydroxybutyric Acid Is a Selective Metabolite Biomarker of Impaired Glucose Tolerance , 2016, Diabetes Care.

[4]  Samantha L. Hoopes,et al.  Vascular actions of 20-HETE. , 2015, Prostaglandins & other lipid mediators.

[5]  Heqing Shen,et al.  Serum metabolomics reveals that arsenic exposure disrupted lipid and amino acid metabolism in rats: a step forward in understanding chronic arsenic toxicity. , 2015, Metallomics : integrated biometal science.

[6]  Heqing Shen,et al.  Urinary Metabolomics Revealed Arsenic Internal Dose-Related Metabolic Alterations: A Proof-of-Concept Study in a Chinese Male Cohort , 2014, Environmental science & technology.

[7]  Heqing Shen,et al.  Metabolomic analysis reveals a unique urinary pattern in normozoospermic infertile men. , 2014, Journal of proteome research.

[8]  Yali Shi,et al.  Highly elevated serum concentrations of perfluoroalkyl substances in fishery employees from Tangxun lake, china. , 2014, Environmental science & technology.

[9]  Y. Lee,et al.  Perfluoroalkyl acids in blood serum samples from children in Taiwan , 2014, Environmental Science and Pollution Research.

[10]  Yifeng Zhang,et al.  Serum levels of perfluoroalkyl acids (PFAAs) with isomer analysis and their associations with medical parameters in Chinese pregnant women. , 2014, Environment international.

[11]  Siyuan Peng,et al.  An integrated metabonomics and transcriptomics approach to understanding metabolic pathway disturbance induced by perfluorooctanoic acid. , 2013, Journal of pharmaceutical and biomedical analysis.

[12]  Heqing Shen,et al.  Perfluorooctanoic acid induces apoptosis through the p53-dependent mitochondrial pathway in human hepatic cells: a proteomic study. , 2013, Toxicology letters.

[13]  C. Wong,et al.  Blood plasma concentrations of endocrine disrupting chemicals in Hong Kong populations. , 2013, Journal of hazardous materials.

[14]  A. Calafat,et al.  Polyfluorinated compounds in dust from homes, offices, and vehicles as predictors of concentrations in office workers' serum. , 2013, Environment international.

[15]  A. Shankar,et al.  Positive association between perfluoroalkyl chemicals and hyperuricemia in children. , 2013, American journal of epidemiology.

[16]  Jonathan W. Martin,et al.  Isomers of perfluorooctanesulfonate and perfluorooctanoate and total perfluoroalkyl acids in human serum from two cities in North China. , 2013, Environment international.

[17]  N. V. van Larebeke,et al.  Endocrine-Disrupting Chemicals: Associated Disorders and Mechanisms of Action , 2012, Journal of environmental and public health.

[18]  Heqing Shen,et al.  Perfluorooctanoic acid induces gene promoter hypermethylation of glutathione-S-transferase Pi in human liver L02 cells. , 2012, Toxicology.

[19]  Heqing Shen,et al.  Evaluation of cellular response to perfluorooctane sulfonate in human umbilical vein endothelial cells. , 2012, Toxicology in vitro : an international journal published in association with BIBRA.

[20]  J. Domingo,et al.  Health risks of dietary exposure to perfluorinated compounds. , 2012, Environment international.

[21]  E. Mariussen.  Neurotoxic effects of perfluoroalkylated compounds: mechanisms of action and environmental relevance , 2012, Archives of Toxicology.

[22]  G. Luo,et al.  Intrarenal metabolomics reveals the association of local organic toxins with the progression of diabetic kidney disease. , 2012, Journal of pharmaceutical and biomedical analysis.

[23]  J. Atzrodt,et al.  The synthesis of selected phase II metabolites – Ο-glucuronides and sulfates of drug development candidates , 2012 .

[24]  Esben Budtz-Jørgensen,et al.  Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. , 2012, JAMA.

[25]  S. Fenton,et al.  Endocrine disrupting properties of perfluorooctanoic acid , 2011, The Journal of Steroid Biochemistry and Molecular Biology.

[26]  Zi Yang,et al.  Inhibition of nitric oxide synthase lowers fatty acid oxidation in preeclampsia-like mice at early gestational stage. , 2011, Chinese medical journal.

[27]  Mark J. Strynar,et al.  Polyfluorinated compounds: past, present, and future. , 2011, Environmental science & technology.

[28]  J. F. Stevens,et al.  Vitamins C and E: beneficial effects from a mechanistic perspective. , 2011, Free radical biology & medicine.

[29]  B. Halliwell,et al.  Artefacts in cell culture: α-Ketoglutarate can scavenge hydrogen peroxide generated by ascorbate and epigallocatechin gallate in cell culture media. , 2011, Biochemical and biophysical research communications.

[30]  C. Thomsen,et al.  Levels in food and beverages and daily intake of perfluorinated compounds in Norway. , 2010, Chemosphere.

[31]  Andrea Natali,et al.  α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population , 2010, PloS one.

[32]  T. Webster,et al.  Exposure to Polyfluoroalkyl Chemicals and Cholesterol, Body Weight, and Insulin Resistance in the General U.S. Population , 2009, Environmental health perspectives.

[33]  Kyle Steenland,et al.  Association of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) with Uric Acid among Adults with Elevated Community Exposure to PFOA , 2009, Environmental health perspectives.

[34]  J. Depierre,et al.  High-dose, short-term exposure of mice to perfluorooctanesulfonate (PFOS) or perfluorooctanoate (PFOA) affects the number of circulating neutrophils differently, but enhances the inflammatory responses of macrophages to lipopolysaccharide (LPS) in a similar fashion. , 2009, Toxicology.

[35]  J. Depierre,et al.  The atrophy and changes in the cellular compositions of the thymus and spleen observed in mice subjected to short-term exposure to perfluorooctanesulfonate are high-dose phenomena mediated in part by peroxisome proliferator-activated receptor-alpha (PPARalpha). , 2009, Toxicology.

[36]  Mark R. Viant,et al.  Environmental metabolomics: a critical review and future perspectives , 2009, Metabolomics.

[37]  D. Mozaffarian,et al.  Omega-6 Fatty Acids and Risk for Cardiovascular Disease: A Science Advisory From the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention , 2009, Circulation.

[38]  L. Sobrevia,et al.  A hypothesis for preeclampsia: adenosine and inducible nitric oxide synthase in human placental microvascular endothelium. , 2008, Placenta.

[39]  A. A. Jensen,et al.  Emerging endocrine disrupters: perfluoroalkylated substances. , 2008, International journal of andrology.

[40]  A Dick Vethaak,et al.  Accumulation of perfluorooctane sulfonate (PFOS) in the food chain of the Western Scheldt estuary: Comparing field measurements with kinetic modeling. , 2008, Chemosphere.

[41]  C. Lau,et al.  Perfluoroalkyl acids: a review of monitoring and toxicological findings. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[42]  B. van Ravenzwaay,et al.  The use of metabolomics for the discovery of new biomarkers of effect. , 2007, Toxicology letters.

[43]  M. Traber,et al.  Vitamin E, antioxidant and nothing more. , 2007, Free radical biology & medicine.

[44]  A. Koizumi,et al.  Historical trends in human serum levels of perfluorooctanoate and perfluorooctane sulfonate in Shenyang, China. , 2007, The Tohoku journal of experimental medicine.

[45]  K. Yu,et al.  Induction of oxidative stress and apoptosis by PFOS and PFOA in primary cultured hepatocytes of freshwater tilapia (Oreochromis niloticus). , 2007, Aquatic toxicology.

[46]  K. Sasaki,et al.  [Comparison of perfluorooctane sulfonate and perfluorooctane acid in serum of non-occupational human from Shenyang and Chongqing areas]. , 2006, Wei sheng yan jiu = Journal of hygiene research.

[47]  L. Shaw,et al.  Community Exposure to Perfluorooctanoate: Relationships Between Serum Concentrations and Exposure Sources , 2006, Journal of occupational and environmental medicine.

[48]  Xiaofeng Yao,et al.  Genotoxic risk and oxidative DNA damage in HepG2 cells exposed to perfluorooctanoic acid. , 2005, Mutation research.

[49]  S. Tyagi,et al.  Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle , 2004, Nutrition & metabolism.

[50]  R. Feinman,et al.  What is Nutrition & Metabolism? , 2004, Nutrition & Metabolism.

[51]  C. Lau,et al.  The developmental toxicity of perfluoroalkyl acids and their derivatives. , 2004, Toxicology and applied pharmacology.

[52]  M. Roberfroid,et al.  Peroxisomal Enzymes and 8-Hydroxydeoxyguanosine in Rat Liver Treated with Perfluorooctanoic Acid , 2004, Disease markers.

[53]  R. Henning,et al.  Protective role of endothelial nitric oxide synthase , 2003, The Journal of pathology.

[54]  D. Madge,et al.  Synthesis and analysis of conjugates of the major vitamin E metabolite, α-CEHC , 2002 .

[55]  R. Parker,et al.  Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. , 2002, The Journal of biological chemistry.

[56]  Qiang Yang,et al.  Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice. , 2001, Biochemical pharmacology.

[57]  D. Grandér,et al.  Reactive oxygen species and mitochondria mediate the induction of apoptosis in human hepatoma HepG2 cells by the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid. , 2001, Toxicology and applied pharmacology.

[58]  J. Giesy,et al.  Global distribution of perfluorooctane sulfonate in wildlife. , 2001, Environmental science & technology.

[59]  J. Depierre,et al.  Effects of peroxisome proliferators on the thymus and spleen of mice , 2000, Clinical and experimental immunology.

[60]  J. Lindon,et al.  'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. , 1999, Xenobiotica; the fate of foreign compounds in biological systems.

[61]  N. Weintraub,et al.  Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation. , 1998, Circulation research.

[62]  James B. Mitchell,et al.  The multifaceted roles of nitric oxide in cancer. , 1998, Carcinogenesis.

[63]  T. Yamazaki,et al.  15-lipoxygenase metabolite(s) of arachidonic acid mediates adrenocorticotropin action in bovine adrenal steroidogenesis. , 1996, Endocrinology.

[64]  G. J. Van Der Kraak,et al.  Mechanisms of action of free arachidonic acid on ovarian steroid production in the goldfish. , 1996, General and comparative endocrinology.

[65]  M. Mcdaniel,et al.  Aminoguanidine, a Novel Inhibitor of Nitric Oxide Formation, Prevents Diabetic Vascular Dysfunction , 1992, Diabetes.

[66]  A. Peitzman,et al.  Nitrogen oxide levels in patients after trauma and during sepsis. , 1991, Annals of surgery.

[67]  P. Proctor.  Similar Functions of Uric Acid and Ascorbate in Man ? , 1970, Nature.

[68]  Heqing Shen,et al.  Online background cleanup followed by high-performance liquid chromatography with tandem mass spectrometry for the analysis of perfluorinated compounds in human blood. , 2015, Journal of separation science.

[69]  A. Angerhofer,et al.  Uric Acid and Oxidative Stress , 2011 .

[70]  Paul D Jones,et al.  Gene expression profiles in rat liver treated with perfluorooctanoic acid (PFOA). , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[71]  T Tsutsui,et al.  Airborne Perfluorooctanoate May Be a Substantial Source Contamination in Kyoto Area, Japan , 2005, Bulletin of environmental contamination and toxicology.